Evidence map›Paper›PMID 32513908›Full record

ReviewThe American journal of case reports2020

Septic Shock and Purpura Fulminans Due to Streptococcus pneumoniae Bacteremia in an Unvaccinated Immunocompetent Adult: Case Report and Review.

Nikola Djurdjevic, Pahnwat Tonya Taweesedt, Margaret Paulson, Abigail LaNou, Milan Radovanovic, Janki N Patel, Mladjen Veselinovic, Wendy R McDermott, Igor Dumic

Open access · hybridAbstract readCase ReportsReview
In one paragraph

Review in The American journal of case reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. When Fever Strikes Twice: A Case Report ofInfectious disease reports · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Purpura fulminans due toBMJ case reports · 2022
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Nikola DjurdjevicIcahn School of Medicine at Mount Sinai, New York City, NY, USA.
Pahnwat Tonya TaweesedtIcahn School of Medicine at Mount Sinai, New York City, NY, USA.
Margaret PaulsonMayo Clinic, Alix School of Medicine, Rochester, MN, USA.
Abigail LaNouMayo Clinic, Alix School of Medicine, Rochester, MN, USA.
Milan RadovanovicMayo Clinic, Alix School of Medicine, Rochester, MN, USA.
Janki N PatelMayo Clinic, Alix School of Medicine, Rochester, MN, USA.
Mladjen VeselinovicUniversity of Utah School of Medicine, Salt Lake City, UT, USA.
Wendy R McDermottMayo Clinic, Alix School of Medicine, Rochester, MN, USA.
Igor DumicMayo Clinic, Alix School of Medicine, Rochester, MN, USA.
Mayo Clinic · USIcahn School of Medicine at Mount Sinai · USUniversity of Utah · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND Despite proven efficacy of vaccinations against Streptococcus pneumoniae in preventing infection, only 70% of eligible individuals receive the vaccine in the United States. Pneumococcal bacteremia represents a form of invasive pneumococcal disease and is associated with high mortality, especially in immunocompromised patients and the elderly. Purpura fulminans is a rare complication and manifestation of disseminated intravascular coagulation and sepsis. It is exceedingly rare in the setting of pneumococcal bacteremia, particularly in immunocompetent individuals. CASE REPORT We report a generally healthy 67-year-old male with schizophrenia who refused pneumococcal vaccination. He had an intact and functional spleen with a functional immune system. The patient presented with fever and diarrhea. He subsequently progressed to develop purpura fulminans and septic shock due to S. pneumoniae bacteremia. Despite an extensive search for the primary source of infection, none could not be identified. Due to timely initiation of appropriate antibiotic therapy and aggressive supportive care in an intensive care unit, he recovered despite multi-organ failure that developed throughout his hospitalization. CONCLUSIONS We present a rare manifestation of a potentially preventable disease and emphasize the importance of pneumococcal vaccination in order to decrease the risk of developing invasive pneumococcal disease. Furthermore, we discuss etiology, diagnosis, differential diagnosis, and evidence-based management of purpura fulminans and invasive pneumococcal disease with a literature review. Purpura fulminans due to S. pneumoniae is exceedingly rare in immunocompetent patients and an unusual clinical manifestation of pneumococcal bacteremia.

Indexed as

Vaccination RefusalAgedAnti-Bacterial AgentsBacteremiaCeftriaxoneDiagnosis, DifferentialHumansMalePneumococcal InfectionsPurpura FulminansShock, SepticStreptococcus pneumoniaeAnti-Bacterial AgentsCeftriaxone

Identifiers

PMID32513908
PMCPMC7304654
OpenAlexW3025373510

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.